Education
About Us
Working with TipRanks
Follow Us
BioLargo Inc (BLGO)
OTHER OTC:BLGO
BLGO Stock Chart & Stats
$0.19
<$0.01(0.17%)
At close: 4:00 PM EST
$0.19
<$0.01(0.17%)
Day’s Range― - ―
52-Week Range$0.14 - $0.30
Previous CloseN/A
Volume222.28K
Average Volume (3M)570.01K
Market Cap
$56.16M
Enterprise Value$53.22M
Total Cash (Recent Filing)$4.55M
Total Debt (Recent Filing)$1.49M
Price to Earnings (P/E)―
Beta-0.33
Next Earnings
Apr 06, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding313,762,660
10 Day Avg. Volume632,227
30 Day Avg. Volume570,010
Financial Highlights & Ratios
PEG Ratio0.69
Price to Book (P/B)6.40
Price to Sales (P/S)3.19
P/FCF Ratio-12.75
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue4.93
Enterprise Value/Gross Profit10.58
Enterprise Value/Ebitda-4.68
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BioLargo News
BLGO FAQ
What was BioLargo Inc’s price range in the past 12 months?
BioLargo Inc lowest stock price was $0.14 and its highest was $0.30 in the past 12 months.
What is BioLargo Inc’s market cap?
BioLargo Inc’s market cap is $56.16M.
When is BioLargo Inc’s upcoming earnings report date?
BioLargo Inc’s upcoming earnings report date is Apr 06, 2026 which is in 62 days.
How were BioLargo Inc’s earnings last quarter?
BioLargo Inc released its earnings results on Nov 17, 2025. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of $0 by -$0.02.
Is BioLargo Inc overvalued?
According to Wall Street analysts BioLargo Inc’s price is currently Overvalued.
Does BioLargo Inc pay dividends?
BioLargo Inc does not currently pay dividends.
What is BioLargo Inc’s EPS estimate?
BioLargo Inc’s EPS estimate is -0.01.
How many shares outstanding does BioLargo Inc have?
BioLargo Inc has 313,762,660 shares outstanding.
What happened to BioLargo Inc’s price movement after its last earnings report?
BioLargo Inc reported an EPS of -$0.02 in its last earnings report, missing expectations of $0. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BioLargo Inc?
Currently, no hedge funds are holding shares in BLGO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BioLargo Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.75%
12-Months-Change
Fundamentals
Return on Equity
-129.84%
Trailing 12-Months
Asset Growth
24.33%
Trailing 12-Months
Company Description
BioLargo Inc
BioLargo, Inc. invents, develops, and commercializes various platform technologies. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. It holds various issued patents, maintains a pipeline of products, and provides full-service environmental engineering services. The company's products include Advanced Oxidation system, a water treatment device that generates a series of oxidative and energetic species of iodine and other molecules; Aqueous Electrostatic Concentrator, a water treatment system that removes per- and poly-fluoroalkyl substances from water; CupriDyne Clean industrial products, which reduce and eliminate tough odors and volatile organic compounds in various industrial settings; and advanced wound care products. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.
BLGO Company Deck
BLGO Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a balanced outlook, with significant technological advancements and partnerships highlighted. However, these are offset by financial challenges and legal disputes, particularly with Pooph, which have impacted the company's financials and operations.View all BLGO earnings summariesTechnical Analysis
Ownership Overview
13.13% Insiders
0.04% Other Institutional Investors
86.83% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---